[Double blind trial of hexoprenaline as a bronchodilator].
D000402:Airway Obstruction / Q000188:drug therapy*; D000403:Airway Resistance / Q000187:drug effects; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002396:Catechols / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004562:Electrocardiography; D004983:Ethanolamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010627:Phenethylamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D013997:Time Factors
D001786:Blood Glucose; D001993:Bronchodilator Agents; D002396:Catechols; D004983:Ethanolamines; D010627:Phenethylamines; D010919:Placebos
Doppelbindversuch mit Hexoprenalin als Bronchodilatator